NCT03878030View on ClinicalTrials.gov

Effect of Nusinersen on Adults With Spinal Muscular Atrophy

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

July 13, 2021

Study Completion Date

July 13, 2021

Conditions

Adult Spinal Muscular Atrophy

Interventions

DRUG

nusinersen

Subjects will receive nusinersen and be observed with motor assessments for 24 months

Trial Locations (1)

11021

Northwell Health Neuroscience, Great Neck

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

lead

Northwell Health

OTHER

NCT03878030 - Effect of Nusinersen on Adults With Spinal Muscular Atrophy | Biotech Hunter | Biotech Hunter